Search

Chinese
Resource Library / The Next Generation Central Lab

webinar

The Next Generation Central Lab

Watch our webinar outlining the next general central lab services that provide lab assessments, kits, logistics support, and delivery of data in certain formats. Frontage can provide lab testing on both medical diagnostics and clinical trial spaces.

Resource Preview

Resources to Consider

Left arrow
Addressing the Increasing Needs of Data Integrity by Implementing the ElectronicSystems in a Paperless Bioanalytical Laboratory
Access Resource
Genotoxic Potential of Benzo[b]Fluoranthene (B[b]F):A Probable Human Carcinogen
poster

Genotoxic Potential of Benzo[b]Fluoranthene (B[b]F):A Probable Human...
Explore our EMGS 2025 poster on the Genotoxic Potential of Benzo[b]fluoranthene (B[b]F). T...
Access Resource
WRIB 2025: Validation of an Ultra-High Sensitive Simoa Assay for the Quantitation of IL-17A in Human Serum
Access Resource
WRIB 2025: Innovative Strategy for Overcoming pH-Related Assay Variation in the Development and Validation of a Pharmacokinetic Assay for OBI-992, a TROP2-Targeting Exatecan-Based Antibody-Drug Conjugate, in Human Serum
Access Resource
AACR 2023: Evaluation of a 293 gene oncology-focused exome sequencing panel for screening of ovarian cancer patients for BRCA mutations as a rerequisite for manufacturing of an autologous cellular immunotherapy
poster

AACR 2023: Evaluation of a 293 gene oncology-focused exome sequencing...
Frontage Genomics Services has validated a custom-designed 293 cancer-related genes panel....
Access Resource
Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response
journal

Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of...
This Phase 1 proof‑of‑principle study shows that combining Vigil (a personalized tum...
Access Resource
WebninarAnalytical Challenges for CMC Development of Cell and Gene Therapy ProductsWebninar
webinar

WebninarAnalytical Challenges for CMC Development of Cell and Gene...
In this webinar we will cover:
Innovative solutions and best practices for accelera...
Access Resource
Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using the Simoa HD-X platform
poster

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...
Alzheimer’s disease (AD) is a neurodegenerative disorder which stands as one of the most...
Access Resource
Nonclinical Vehicle Formulations:HP-β-CD (Hydroxypropyl-Beta-Cyclodextrin) & The Risk of Hemolysis
poster

Nonclinical Vehicle Formulations:HP-β-CD...
Beta-cyclodextrin is a commonly used excipient in nonclinical vehicle formulations. In a r...
Access Resource
Evaluating the feasibility of lyophilization for oral formulation development of monoclonal antibodies (mAbs)​
poster

Evaluating the feasibility of lyophilization for oral formulation...
Objective: To develop a stable lyophilized non-invasive oral formulation of monoclonal ant...
Access Resource
Identification of the Major Circulating Metabolite of Mymd-1 And Elucidation of the Mechanism of Clearance of MYMD-1 in Humans. Role of Aldehyde Oxidase and CYP2A6
poster

Identification of the Major Circulating Metabolite of Mymd-1 And...
MYMD-1 is an immunomodulator that is currently entering Phase II clinical development for ...
Access Resource
IN Vitro Assessment of the inhibition of Human Organic Anion Transporting Polypeptide 1B1/1B3 by Highly Bound Plasma Proteins Compounds in the Presence of Physiological Concentration of Human Serum Albumin 
poster

IN Vitro Assessment of the inhibition of Human Organic Anion...
The present study was aimed to validate this alternate approach to assess inhibition of or...
Access Resource
Right arrow